{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:48:59Z","timestamp":1787003339555,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["448323"],"award-info":[{"award-number":["448323"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-024-01259-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:02:30Z","timestamp":1732770150000},"page":"822-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses"],"prefix":"10.1038","volume":"9","author":[{"given":"Reza","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Petryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4586-3629","authenticated-orcid":false,"given":"Miles","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Kooshki Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-3650","authenticated-orcid":false,"given":"Ragunath","family":"Singaravelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"St-Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Pelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Poutou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abril Ixchel","family":"Munoz Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria H.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zumama","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal Alper","family":"Onsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Marius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazel","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Nik-Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Alwithenani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Panahi Arasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S. G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.","family":"Hobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-9138","authenticated-orcid":false,"given":"Tommy","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Hwa","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S.","family":"Ilkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Simon","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-357X","authenticated-orcid":false,"given":"John C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9498-0657","authenticated-orcid":false,"given":"Taha","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.mt.6300108","volume":"15","author":"E Kelly","year":"2007","unstructured":"Kelly, E. & Russell, S. J. History of oncolytic viruses: genesis to genetic engineering. Mol. Ther. 15, 651\u2013659 (2007).","journal-title":"Mol. Ther."},{"key":"1259_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.omtm.2020.01.001","volume":"17","author":"A Lemos de Matos","year":"2020","unstructured":"Lemos de Matos, A., Franco, L. S. & McFadden, G. Oncolytic viruses and the immune system: the dynamic duo. Mol. Ther. Methods Clin. Dev. 17, 349\u2013358 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1259_CR3","doi-asserted-by":"publisher","first-page":"1324744","DOI":"10.3389\/fimmu.2023.1324744","volume":"14","author":"L Xu","year":"2023","unstructured":"Xu, L., Sun, H., Lemoine, N. R., Xuan, Y. & Wang, P. Oncolytic vaccinia virus and cancer immunotherapy. Front. Immunol. 14, 1324744 (2023).","journal-title":"Front. Immunol."},{"key":"1259_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/14712598.2020.1757066","volume":"20","author":"A Pelin","year":"2020","unstructured":"Pelin, A., Boulton, S., Tamming, L. A., Bell, J. C. & Singaravelu, R. Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. Expert Opin. Biol. Ther. 20, 1083\u20131097 (2020).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1259_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cytogfr.2018.03.006","volume":"41","author":"JF De Graaf","year":"2018","unstructured":"De Graaf, J. F., de Vor, L., Fouchier, R. A. M. & van den Hoogen, B. G. Armed oncolytic viruses: a kick-start for anti-tumor immunity. Cytokine Growth Factor Rev. 41, 28\u201339 (2018).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1259_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","volume":"8","author":"D Lin","year":"2023","unstructured":"Lin, D., Shen, Y. & Liang, T. Oncolytic virotherapy: basic principles, recent advances and future directions. Signal Transduct. Target. Ther. 8, 156 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1259_CR7","first-page":"13","volume":"11","author":"KA Parato","year":"2009","unstructured":"Parato, K. A., Lichty, B. D. & Bell, J. C. Diplomatic immunity: turning a foe into an ally. Curr. Opin. Mol. Ther. 11, 13\u201321 (2009).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"1259_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.2994215","volume":"229","author":"B Roizman","year":"1985","unstructured":"Roizman, B. & Jenkins, F. J. Genetic engineering of novel genomes of large DNA viruses. Science 229, 1208\u20131214 (1985).","journal-title":"Science"},{"key":"1259_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-virology-091919-104752","volume":"9","author":"MD Greseth","year":"2022","unstructured":"Greseth, M. D. & Traktman, P. The life cycle of the vaccinia virus genome. Annu. Rev. Virol. 9, 239\u2013259 (2022).","journal-title":"Annu. Rev. Virol."},{"key":"1259_CR10","doi-asserted-by":"publisher","first-page":"15010","DOI":"10.1038\/mto.2015.10","volume":"2","author":"C Peters","year":"2015","unstructured":"Peters, C. & Rabkin, S. D. Designing herpes viruses as oncolytics. Mol. Ther. Oncolytics 2, 15010 (2015).","journal-title":"Mol. Ther. Oncolytics"},{"key":"1259_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","volume":"158","author":"R Blasco","year":"1995","unstructured":"Blasco, R. & Moss, B. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158, 157\u2013162 (1995).","journal-title":"Gene"},{"key":"1259_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s42003-020-01374-6","volume":"3","author":"A Gowripalan","year":"2020","unstructured":"Gowripalan, A., Smith, S., Stefanovic, T. & Tscharke, D. C. Rapid poxvirus engineering using CRISPR\/Cas9 as a selection tool. Commun. Biol. 3, 643 (2020).","journal-title":"Commun. Biol."},{"key":"1259_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4939-9814-2_9","volume":"2060","author":"T Velusamy","year":"2020","unstructured":"Velusamy, T., Gowripalan, A. & Tscharke, D. C. CRISPR\/Cas9-based genome editing of HSV. Methods Mol. Biol. 2060, 169\u2013183 (2020).","journal-title":"Methods Mol. Biol."},{"key":"1259_CR14","doi-asserted-by":"publisher","first-page":"1050250","DOI":"10.3389\/fimmu.2022.1050250","volume":"13","author":"JT Whelan","year":"2023","unstructured":"Whelan, J. T. et al. CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX. Front. Immunol. 13, 1050250 (2023).","journal-title":"Front. Immunol."},{"key":"1259_CR15","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/microorganisms9061260","volume":"9","author":"Y Liao","year":"2021","unstructured":"Liao, Y., Bajwa, K., Reddy, S. M. & Lupiani, B. Methods for the manipulation of herpesvirus genome and the application to Marek\u2019s disease virus research. Microorganisms 9, 1260 (2021).","journal-title":"Microorganisms"},{"key":"1259_CR16","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1128\/JVI.75.15.6923-6932.2001","volume":"75","author":"XD Yao","year":"2001","unstructured":"Yao, X. D. & Evans, D. H. Effects of DNA structure and homology length on vaccinia virus recombination. J. Virol. 75, 6923\u20136932 (2001).","journal-title":"J. Virol."},{"key":"1259_CR17","doi-asserted-by":"publisher","first-page":"a012351","DOI":"10.1101\/cshperspect.a012351","volume":"5","author":"D Walsh","year":"2013","unstructured":"Walsh, D., Mathews, M. B. & Mohr, I. Tinkering with translation: protein synthesis in virus-infected cells. Cold Spring Harb. Perspect. Biol. 5, a012351 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1259_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","volume":"2","author":"MG Katze","year":"2002","unstructured":"Katze, M. G., He, Y. & Gale, M. Jr. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675\u2013687 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1259_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/pathogens9050400","volume":"9","author":"P Dhungel","year":"2020","unstructured":"Dhungel, P., Cantu, F. M., Molina, J. A. & Yang, Z. Vaccinia virus as a master of host shutoff induction: targeting processes of the central dogma and beyond. Pathogens 9, 400 (2020).","journal-title":"Pathogens"},{"key":"1259_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/ecosalplus.esp-0002-2018","volume":"8","author":"AW Serio","year":"2018","unstructured":"Serio, A. W., Keepers, T., Andrews, L. & Krause, K. M. Aminoglycoside revival: review of a historically important class of antimicrobials undergoing rejuvenation. EcoSal Plus 8, 1\u201320 (2018).","journal-title":"EcoSal Plus"},{"key":"1259_CR21","doi-asserted-by":"publisher","first-page":"100838","DOI":"10.1016\/j.jbc.2021.100838","volume":"297","author":"C Guo","year":"2021","unstructured":"Guo, C., Fordjour, F. K., Tsai, S. J., Morrell, J. C. & Gould, S. J. Choice of selectable marker affects recombinant protein expression in cells and exosomes. J. Biol. Chem. 297, 100838 (2021).","journal-title":"J. Biol. Chem."},{"key":"1259_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.csbj.2020.04.014","volume":"18","author":"R Aviner","year":"2020","unstructured":"Aviner, R. The science of puromycin: from studies of ribosome function to applications in biotechnology. Comput. Struct. Biotechnol. J. 18, 1074\u20131083 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1259_CR23","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1093\/nar\/11.19.6895","volume":"11","author":"KR Kaster","year":"1983","unstructured":"Kaster, K. R., Burgett, S. G., Rao, R. N. & Ingolia, T. D. Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing. Nucleic Acids Res. 11, 6895\u20136911 (1983).","journal-title":"Nucleic Acids Res."},{"key":"1259_CR24","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1093\/nar\/gkab532","volume":"49","author":"KT Powers","year":"2021","unstructured":"Powers, K. T. et al. Blasticidin S inhibits mammalian translation and enhances production of protein encoded by nonsense mRNA. Nucleic Acids Res. 49, 7665\u20137679 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1259_CR25","doi-asserted-by":"publisher","first-page":"e1003836","DOI":"10.1371\/journal.ppat.1003836","volume":"10","author":"CS Ilkow","year":"2014","unstructured":"Ilkow, C. S., Swift, S. L., Bell, J. C. & Diallo, J.-S. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathog. 10, e1003836 (2014).","journal-title":"PLoS Pathog."},{"key":"1259_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/v13010017","volume":"13","author":"C Dogrammatzis","year":"2020","unstructured":"Dogrammatzis, C., Waisner, H. & Kalamvoki, M. \u201cNon-essential\u201d proteins of HSV-1 with essential roles in vivo: a comprehensive review. Viruses 13, 17 (2020).","journal-title":"Viruses"},{"key":"1259_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ymthe.2003.11.009","volume":"9","author":"Z Izsv\u00e1k","year":"2004","unstructured":"Izsv\u00e1k, Z. & Ivics, Z. Sleeping Beauty transposition: biology and applications for molecular therapy. Mol. Ther. 9, 147\u2013156 (2004).","journal-title":"Mol. Ther."},{"key":"1259_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38651-x","volume":"14","author":"T Azad","year":"2023","unstructured":"Azad, T. et al. Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies. Nat. Commun. 14, 3035 (2023).","journal-title":"Nat. Commun."},{"key":"1259_CR29","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Zhao, Y., Bollas, A., Wang, Y. & Au, K. F. Nanopore sequencing technology, bioinformatics and applications. Nat. Biotechnol. 39, 1348\u20131365 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1259_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/v8050134","volume":"8","author":"S Al Ali","year":"2016","unstructured":"Al Ali, S., Baldanta, S., Fern\u00e1ndez-Escobar, M. & Guerra, S. Use of reporter genes in the generation of vaccinia virus-derived vectors. Viruses 8, 134 (2016).","journal-title":"Viruses"},{"key":"1259_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1128\/jvi.66.5.2617-2630.1992","volume":"66","author":"MS Lee","year":"1992","unstructured":"Lee, M. S. et al. Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J. Virol. 66, 2617\u20132630 (1992).","journal-title":"J. Virol."},{"key":"1259_CR32","doi-asserted-by":"publisher","first-page":"1038226","DOI":"10.3389\/fimmu.2022.1038226","volume":"13","author":"L Palanivelu","year":"2023","unstructured":"Palanivelu, L., Liu, C.-H. & Lin, L.-T. Immunogenic cell death: the cornerstone of oncolytic viro-immunotherapy. Front. Immunol. 13, 1038226 (2023).","journal-title":"Front. Immunol."},{"key":"1259_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers10070216","volume":"10","author":"T Krabbe","year":"2018","unstructured":"Krabbe, T. & Altomonte, J. Fusogenic viruses in oncolytic immunotherapy. Cancers (Basel) 10, 216 (2018).","journal-title":"Cancers (Basel)"},{"key":"1259_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova, J. et al. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 11, 1013 (2020).","journal-title":"Cell Death Dis."},{"key":"1259_CR35","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1073\/pnas.101136398","volume":"98","author":"T Todo","year":"2001","unstructured":"Todo, T., Martuza, R. L., Rabkin, S. D. & Johnson, P. A. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc. Natl Acad. Sci. USA 98, 6396\u20136401 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1259_CR36","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1128\/JVI.00017-12","volume":"86","author":"R Kanai","year":"2012","unstructured":"Kanai, R. et al. Effect of \u03b334.5 deletions on oncolytic herpes simplex virus activity in brain tumors. J. Virol. 86, 4420\u20134431 (2012).","journal-title":"J. Virol."},{"key":"1259_CR37","doi-asserted-by":"publisher","first-page":"e1005449","DOI":"10.1371\/journal.ppat.1005449","volume":"12","author":"DR Wilcox","year":"2016","unstructured":"Wilcox, D. R. & Longnecker, R. The herpes simplex virus neurovirulence factor \u03b334.5: revealing virus\u2013host interactions. PLoS Pathog. 12, e1005449 (2016).","journal-title":"PLoS Pathog."},{"key":"1259_CR38","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.2173860","volume":"250","author":"J Chou","year":"1990","unstructured":"Chou, J., Kern, E. R., Whitley, R. J. & Roizman, B. Mapping of herpes simplex virus-1 neurovirulence to \u03b3134.5, a gene nonessential for growth in culture. Science 250, 1262\u20131266 (1990).","journal-title":"Science"},{"key":"1259_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nbt.3198","volume":"33","author":"VT Chu","year":"2015","unstructured":"Chu, V. T. et al. Increasing the efficiency of homology-directed repair for CRISPR\u2013Cas9-induced precise gene editing in mammalian cells. Nat. Biotechnol. 33, 543\u2013548 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1259_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/crispr.2021.0017","volume":"4","author":"N Tang","year":"2021","unstructured":"Tang, N., Zhang, Y., Shen, Z., Yao, Y. & Nair, V. Application of CRISPR\u2013Cas9 editing for virus engineering and the development of recombinant viral vaccines. CRISPR J. 4, 477\u2013490 (2021).","journal-title":"CRISPR J."},{"key":"1259_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.virol.2006.11.022","volume":"361","author":"JW Balliet","year":"2007","unstructured":"Balliet, J. W., Kushnir, A. S. & Schaffer, P. A. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice. Virology 361, 372\u2013383 (2007).","journal-title":"Virology"},{"key":"1259_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237\u2013253 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1259_CR43","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-18-1932","volume":"25","author":"HJ Chon","year":"2019","unstructured":"Chon, H. J. et al. Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune-checkpoint blockade. Clin. Cancer Res. 25, 1612\u20131623 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1259_CR44","doi-asserted-by":"publisher","first-page":"eaax7992","DOI":"10.1126\/scitranslmed.aax7992","volume":"12","author":"S Nakao","year":"2020","unstructured":"Nakao, S. et al. Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade. Sci. Transl. Med. 12, eaax7992 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1259_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2022.10.012","volume":"83","author":"B Rozman","year":"2023","unstructured":"Rozman, B., Fisher, T. & Stern-Ginossar, N. Translation\u2014a tug of war during viral infection. Mol. Cell 83, 481\u2013495 (2023).","journal-title":"Mol. Cell"},{"key":"1259_CR46","doi-asserted-by":"publisher","first-page":"a033001","DOI":"10.1101\/cshperspect.a033001","volume":"11","author":"N Stern-Ginossar","year":"2019","unstructured":"Stern-Ginossar, N., Thompson, S. R., Mathews, M. B. & Mohr, I. Translational control in virus-infected cells. Cold Spring Harb. Perspect. Biol. 11, a033001 (2019).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1259_CR47","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1128\/JVI.77.13.7590-7600.2003","volume":"77","author":"C Upton","year":"2003","unstructured":"Upton, C., Slack, S., Hunter, A. L., Ehlers, A. & Roper, R. L. Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J. Virol. 77, 7590\u20137600 (2003).","journal-title":"J. Virol."},{"key":"1259_CR48","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1158\/0008-5472.CAN-04-3227","volume":"65","author":"H Kambara","year":"2005","unstructured":"Kambara, H., Okano, H., Chiocca, E. A. & Saeki, Y. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor. Cancer Res. 65, 2832\u20132839 (2005).","journal-title":"Cancer Res."},{"key":"1259_CR49","doi-asserted-by":"publisher","first-page":"e004167","DOI":"10.1136\/jitc-2021-004167","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang, L., Chard Dunmall, L. S., Cheng, Z. & Wang, Y. Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment. J. Immunother. Cancer 10, e004167 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"1259_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert, C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat. Commun. 11, 3801 (2020).","journal-title":"Nat. Commun."},{"key":"1259_CR51","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.3390\/ijms21228627","volume":"21","author":"JK Hwang","year":"2020","unstructured":"Hwang, J. K., Hong, J. & Yun, C.-O. Oncolytic viruses and immune checkpoint inhibitors: preclinical developments to clinical trials. Int. J. Mol. Sci. 21, 8627 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1259_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/icb.2014.93","volume":"93","author":"AM Huehls","year":"2015","unstructured":"Huehls, A. M., Coupet, T. A. & Sentman, C. L. Bispecific T-cell engagers for cancer immunotherapy. Immunol. Cell Biol. 93, 290\u2013296 (2015).","journal-title":"Immunol. Cell Biol."},{"key":"1259_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-021-01075-5","volume":"14","author":"JPW Heidbuechel","year":"2021","unstructured":"Heidbuechel, J. P. W. & Engeland, C. E. Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. J. Hematol. Oncol. 14, 63 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"1259_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/2159-8290.CD-11-0136","volume":"1","author":"CJ Whatcott","year":"2011","unstructured":"Whatcott, C. J., Han, H., Posner, R. G., Hostetter, G. & Von Hoff, D. D. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov. 1, 291\u2013296 (2011).","journal-title":"Cancer Discov."},{"key":"1259_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.omto.2023.08.013","volume":"30","author":"S-O Hong","year":"2023","unstructured":"Hong, S.-O. et al. Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus. Mol. Ther. Oncolytics 30, 301\u2013315 (2023).","journal-title":"Mol. Ther. Oncolytics"},{"key":"1259_CR56","first-page":"PO.21.00003","volume":"5","author":"O Moaven","year":"2021","unstructured":"Moaven, O., Mangieri, C. W., Stauffer, J. A., Anastasiadis, P. Z. & Borad, M. J. Strategies to develop potent oncolytic viruses and enhance their therapeutic efficacy. JCO Precis. Oncol. 5, PO.21.00003 (2021).","journal-title":"JCO Precis. Oncol."},{"key":"1259_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CJI.0000000000000208","volume":"41","author":"AS Aitken","year":"2018","unstructured":"Aitken, A. S. et al. Brief communication; a heterologous oncolytic bacteria-virus prime-boost approach for anticancer vaccination in mice. J. Immunother. 41, 125\u2013129 (2018).","journal-title":"J. Immunother."},{"key":"1259_CR58","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ymthe.2018.04.001","volume":"26","author":"NT Martin","year":"2018","unstructured":"Martin, N. T. & Bell, J. C. Oncolytic virus combination therapy: killing one bird with two stones. Mol. Ther. 26, 1414\u20131422 (2018).","journal-title":"Mol. Ther."},{"key":"1259_CR59","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/mt.2009.154","volume":"17","author":"BW Bridle","year":"2009","unstructured":"Bridle, B. W. et al. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. Mol. Ther. 17, 1814\u20131821 (2009).","journal-title":"Mol. Ther."},{"key":"1259_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OV.S154494","volume":"7","author":"JG Pol","year":"2018","unstructured":"Pol, J. G. et al. Development and applications of oncolytic Maraba virus vaccines. Oncolytic Virother. 7, 117\u2013128 (2018).","journal-title":"Oncolytic Virother."},{"key":"1259_CR61","first-page":"taab191","volume":"29","author":"B Sapkota","year":"2022","unstructured":"Sapkota, B. et al. Heterologous prime-boost strategies for COVID-19 vaccines. J. Travel Med. 29, taab191 (2022).","journal-title":"J. Travel Med."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01259-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:03:37Z","timestamp":1750269817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01259-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1038\/s41551-024-01259-7","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}